TCAs are best avoided in patients with cardiac
disease. By contrast, the SSRIs have modest effects
on cardiovascular function (although higher doses of
citalopram and escitalopram have been associated
with QT C prolongation) and may have potentially
benefi cial effects on platelet aggregation. Venlafaxine
is usually well tolerated, but blood pressure should
be monitored in patients with hypertension.